primary immunodeficiency syndrome
"Medicare required patients to switch from viva to globulin.  The switch for me resulted in instant disability, numerous infections. It became evident that the same dosage of viva was not equivalent to Hizentra.  Hizentra had to be increased by a factor of 1.59 of viva.  The weekly grams infused out weigh any advantage of the 20% solution."